加拿大联邦政府的主要优先事项仍然是守护加拿大人的健康和安全。在整个疫情大流行期间，联邦政府所采取的快速而果断的行动意味着加拿大能够扩大国内的生物制造能力，而这一能力在过去40多年里一直在下降。政府正在一砖一瓦地重建一个强劲而有竞争力的生物制造和生命科学领域。此举包括通过增强加拿大世界级的高等教育机构和研究医院的研究和人才，以及促进与创新公司的合作，来加强生命科学生态体系的基础。

3月6日，库务委员会主席莫娜·福尔蒂（Mona Fortier）阁下介绍联邦政府投资200万元，用于创建“加拿大大流行病预防中心”（Canadian Pandemic Preparedness Hub）。这项支持是创新、科学和工业部长商鹏飞（François-Philippe Champagne）阁下和卫生部长杜克洛（Jean-Yves Duclos）阁下于 3 月 2 日宣布的 1000 万元投资的一部分，这笔投资用于创建五个研究中心，是加拿大生物医学研究基金（CBRF）和生物科学研究基础设施基金（BRIF）整合竞争第一阶段的一部分。 

“加拿大大流行病预防中心”由渥太华大学和麦克马斯特大学领导。它将促进研究和生物制造方面的创新，以帮助加拿大在未来的大流行病之前生产疫苗、治疗药物和诊断手段。这个多学科研究中心将加速下一代疫苗、疗法和诊断法的研究和开发，同时支持拓展技术人才渠道的培训和发展。它还将加速将有前景的研究成果转化为商业上可行的产品和流程。 

这项投资将有助于加强加拿大生命科学行业的复原力，支持加拿大领先的创新技术研究，守护我们的安全并促进我们的经济。 福尔蒂部长探访渥太华大学，宣布创立加拿大大流行病预防中心。

引述 

创新、科学和工业部长商鹏飞（François-Philippe Champagne）阁下： 

“为了继续保护加拿大人，营造一个有韧力的生物制造生态体系统，我们联邦政府正在采取一切可能的行动以装备最佳的工具。我们很自豪能够在我国自己的实验室里开展所需的相关研究，从而培育尖端的发现和产品，这将帮助我们打造一个更强劲、更健全的生命科学行业，以满足加拿大人未来数十年的需求。” 

卫生部长让-伊夫思·杜克洛（Jean-Yves Duclos）阁下： 

“守护加拿大所有人的健康和安全是我们联邦政府的首要任务。为了使疫苗和治疗领域的工作现代化和取得进步，我们必须继续投资于医疗研究——这就是这些中心将帮助我们实现的目标。我们将与专家、各省份和地区以及其他合作伙伴携手合作，继续共同加强对未来可能出现之疫情大流行的防范。” 

 

库务委员会主席莫娜·福尔蒂（Mona Fortier）阁下： 

“为了加速生命科学的发现并确保加拿大人的健康得到彻底保护，我们必须开展合作并利用多个行业的专业知识。像这样位于国家首都地区的多学科研究中心，由渥太华大学和麦克马斯特大学共同领导，将促进学术界、工业界和社区之间的合作，从而加强加拿大的人才管道，确保人民和社区的福祉。 ” 

渥太华大学科研及创新副校长西尔万·沙邦诺（Sylvain Charbonneau）： 

“我们非常渴望积极为这项开创性的国家努力做出贡献，以发展强劲且具有竞争力的生物制造和生命科学领域。最终目标是使加拿大成为新兴疫苗、治疗方法和诊断方法的全球领导者，增强我们国家预防和应对未来流行病的能力。” 

事实简要 

• 五个研究中心的详细情况： 
• CBRF 大草原中心：在依托在防范疫情大流行方面取得的卓越成就，保护加拿大。由阿尔伯塔大学领导。加快潜在大流行病原体的疫苗、抗病毒药物和诊断对策的开发和商业化。 
• 加拿大的免疫工程和生物制造中心：应对大流行病的免疫工程。 由不列颠哥伦比亚大学领导。帮助开发下一代基于免疫的治疗手段以应对打流行病，这些疗法可以使用生物制造领域的最新创新在国内生产。 
• 加拿大东部防备中心（ECaPH）。由蒙特利尔大学领导。提高加拿大生物制造和生命科学行业的敏捷性、连通性和增长，以确保加拿大为未来的大流行病和公共卫生危机做好准备。 
• 加拿大大流行病预防中心 (CP2H)：由渥太华大学和麦克马斯特大学领导。 促进研究和生物制造创新，帮助加拿大在未来大流行之前生产疫苗、治疗手段和诊断方法。 
• 加拿大传染病健康情报与创新中心 (HI3)：由多伦多大学领导。 推进“个性化和精准医疗”的概念，以影响疫苗、治疗手段和其他公共卫生干预措施的开发。 
• 研究中心是研究和研究培训参与者的联盟，由符合条件的高等教育或医疗研究机构作为中心支柱来协调牵头。这些中心必须具有多学科性质，并拥有跨多个行业的合作伙伴，致力于实现共同目标，以推进大流行病的准备和应对举措。 
• 研究中心的选择以及通过整合CBRF-BRIF 提供的资金将推进加拿大政府的生物制造和生命科学战略，加强加拿大生物制造和生命科学生态系统的研究能力来。 
• 这些新的泛加拿大研究中心是通过两步竞争性审查过程筛选出的，这一过程评估中心的提案与战略的科学价值和战略一致性。 
• 该战略包括多项基础性投资，以帮助营造加拿大的人才管道和研究系统，以及促进加拿大生命科学公司的发展。投资包括： 
• 加拿大生物医学研究基金（CBRF）：2.5 亿加元用于创建支持高风险、应用研究、培训和人才发展合作项目的计划。由加拿大社会科学与人文研究委员会 (SSHRC) 代表三个联邦研究资助机构管理：SSHRC、加拿大卫生研究院 (CIHR) 和加拿大自然科学与工程研究委员会 (NSERC)。 
• 生物科学研究基础设施基金（BRIF）：5 亿元用于支持大专院校和附属研究医院的生物科学基础设施需求。该基金由加拿大创新基金会管理。 
• 在过去两年中，联邦政府已向33 个生物制造、疫苗和治疗项目投入了超过18 亿元。 

相关链接 

Government of Canada establishes a new research hub at the University of Ottawa to accelerate Canada’s vaccine and therapeutics production

https://www.canada.ca/en/innovation-science-economic-development/news/2023/03/government-of-canada-establishes-a-new-research-hub-at-the-university-of-ottawa-to-accelerate-canadas-vaccine-and-therapeutics-production.html

• News release

  This research hub will further strengthen Canada’s biomanufacturing and life sciences sector while protecting Canadians against future health threats

  March 6, 2023 – Ottawa, Ontario

  The Government of Canada’s main priority continues to be protecting the health and safety of Canadians. Throughout the pandemic, the quick and decisive actions taken by the government meant that Canada was able to scale up domestic biomanufacturing capacity, which had been in decline for over 40 years. The government is rebuilding a strong and competitive biomanufacturing and life sciences sector brick by brick. This includes strengthening the foundations of the life sciences ecosystem through the research and talent of Canada’s world-class post-secondary institutions and research hospitals, as well as fostering increased collaboration with innovative companies.

  Today, the Honourable Mona Fortier, President of the Treasury Board, highlighted an investment of $2 million to create the Canadian Pandemic Preparedness Hub. This support is part of a $10 million investment announced by the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, and the Honourable Jean-Yves Duclos, Minister of Health, on March 2 for the creation of five research hubs as part of Stage 1 of the integrated Canada Biomedical Research Fund (CBRF) and Biosciences Research Infrastructure Fund (BRIF) competition.

  The Canadian Pandemic Preparedness Hub is being led by the University of Ottawa and McMaster University. It will catalyze research and biomanufacturing innovations to help Canada produce vaccines, therapeutics and diagnostics ahead of future pandemics. This multidisciplinary research hub will accelerate research and development of next-generation vaccines, therapeutics and diagnostics, while supporting training and development to expand the pipeline of skilled talent. It will also accelerate the translation of promising research into commercially viable products and processes.

  This investment will help strengthen the resilience of Canada’s life sciences sector by supporting leading Canadian research in innovative technologies that keep us safe and boost our economy.

  Quotes

  “To continue to protect Canadians and to build a resilient biomanufacturing ecosystem, our government is taking every action possible to be equipped with the best tools. We’re proud to foster the research needed to produce cutting-edge discoveries and products in our very own labs, which will help us build a stronger, more robust life sciences sector that responds to the needs of Canadians for decades to come.”
  – The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry

  “The health and safety of everyone in Canada is a top priority for our government. To modernize and advance work in the areas of vaccines and therapeutics, we must continue to invest in health research—that is what these hubs will help us achieve. Together, with experts, provinces and territories, and other partners, we will keep strengthening our preparedness for possible future pandemics.”
  – The Honourable Jean-Yves Duclos, Minister of Health

  “To accelerate life sciences discoveries and make sure that the health of Canadians is thoroughly protected, we must collaborate and leverage the expertise of multiple sectors. Multidisciplinary research hubs like this one in the National Capital Region, co-led by the University of Ottawa and McMaster University, will foster collaboration between academia, industry and the community to strengthen Canada’s talent pipeline and ensure the well-being of people and communities.”
  – The Honourable Mona Fortier, President of the Treasury Board

  “We are very eager to actively contribute to this groundbreaking national effort to grow a strong and competitive biomanufacturing and life sciences sector. The ultimate goal is to make Canada a global leader in emerging vaccines, therapeutics and diagnostics, enhancing the national capacity to prevent and respond to future pandemics.” 
  – Sylvain Charbonneau, vice-president, Research and Innovation at the University of Ottawa

  Quick facts

• Details on the five research hubs:

  • The CBRF PRAIRIE Hub: Protecting Canada by Building on Excellence in Pandemic Preparedness. Led by the University of Alberta. Accelerating the development and commercialization of vaccine, antiviral and diagnostic countermeasures for potential pandemic pathogens.
  • Canada’s Immuno-Engineering and Biomanufacturing Hub: Engineering Immunity for Pandemic Response. Led by the University of British Columbia. Helping develop next-generation immune-based therapeutics in response to pandemics that can be manufactured domestically using the latest innovations in biomanufacturing.
  • Eastern Canada Preparedness Hub (ECaPH). Led by the Université de Montréal. Increasing the agility, connectivity and growth of the biomanufacturing and life sciences sector to ensure that Canada is prepared for future pandemics and public health crises.
  • Canadian Pandemic Preparedness Hub (CP2H). Led by the University of Ottawa and McMaster University). Catalyzing research and biomanufacturing innovations to help Canada produce vaccines, therapeutics, and diagnostics ahead of future pandemics.
  • Canadian Hub for Health Intelligence & Innovation in Infectious Diseases (HI3). Led by the University of Toronto. Advancing the concept of ‘personalized and precise medicine’ to influence the development of vaccines, therapeutics and other public health interventions.

• A research hub is a coalition of research and research-training actors, coordinated by an eligible post-secondary or health research institution that serves as an anchor for the hub. Hubs must be multidisciplinary in nature and have partners across a variety of sectors working towards common objectives to advance pandemic readiness and response initiatives.

• The selection of the research hubs and the funding available through the integrated CBRF-BRIF will advance the Government of Canada’s Biomanufacturing and Life Sciences Strategy by strengthening the research capacity of Canada’s biomanufacturing and life sciences ecosystem.

• These new pan-Canadian research hubs were selected through a two-step competitive review process that assessed the scientific merit and strategic alignment of the hub proposals with the strategy.

• The strategy includes multiple foundational investments to help build Canada’s talent pipeline and research systems, as well as foster the growth of Canada’s life sciences firms. Investments include the:

  • Canada Biomedical Research Fund: $250 million to create a program to support high-risk, applied research, training and talent development partnership projects. Administered by the Social Sciences and Humanities Research Council of Canada (SSHRC) on behalf of the three federal research funding agencies: SSHRC, the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC).
  • Biosciences Research Infrastructure Fund: $500 million to support the biosciences infrastructure needs of postsecondary institutions and affiliated research hospitals. This fund is administered by the Canada Foundation for Innovation.

• Over the last two years, the federal government has committed more than $1.8 billion to 33 projects in biomanufacturing, vaccines and therapeutics.

• Associated links

  • Stage 1 integrated CBRF-BRIF results
  • Canada Biomedical Research Fund research hubs selection criteria
  • The Canada Foundation for Innovation’s Biosciences Research Infrastructure Fund

  Contacts

  Monica Granados
  Press Secretary
  Office of the President
  Treasury Board of Canada
  [email protected]

  Laurie Bouchard
  Senior Manager, Communications
  Office of the Minister of Innovation, Science and Industry
  [email protected]

  Media Relations
  Innovation, Science and Economic Development Canada
  [email protected]

  Media Relations
  Tri-agency Institutional Programs Secretariat
  [email protected]

  Stay connected

  Find more services and information at Canada.ca/ISED.

  Follow @CDNScience on social media for Canadian science news: Twitter, Instagram, Facebook

  Search for related information by keyword: EC Economics and Industry | Innovation, Science and Economic Development Canada | Canada | Business and industry | general public | news releases | Hon. Mona Fortier